Thomas Cannell Insider Profile
4 Followers
Thomas Cannell, President & CEO, Director at Carisma Therapeutics, holds 672.39K shares in Carisma Therapeutics (Ticker: CARM), holds 5.09K shares in Orexigen (Ticker: OREXQ).
Thomas Cannell's Trading History
| CARMCarisma Therapeutics | Mar 06, 2023 | President & CEO, Director | Uninformative Buy | 69.20K | $6.72K | |
| OREXQOrexigen | Jun 02, 2017 | ― | Uninformative Buy | 3.28K | $25.45 |
You May Also Like
Thomas Cannell insider profile FAQ
What stocks does Thomas Cannell hold?
Thomas Cannell holds: CARM, OREXQ stocks.
What was Thomas Cannell’s latest transaction?
Thomas Cannell’s latest transaction was an Uninformative Buy of $69.20K.
What is Thomas Cannell's role in Carisma Therapeutics?
Thomas Cannell's role in Carisma Therapeutics is President & CEO, Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.
TipRanks measures corporate insiders by the stock transactions they report to the SEC. See how TipRanks ranks experts and calculates performance.
